EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: A systematic review and meta-analysis

Theodoros Mavridis iD, Paraschos Archontakis-Barakakis iD, David-Dimitris Chlorogiannis, Andreas Charidimou iD

International Journal of Stroke · 2025-10 · 20 (9) · 1049-1059

DOI: 10.1177/17474930251360076 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Stroke, online erschienen am 03.08.2025. Verfasst von Theodoros Mavridis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tallaght University Hospital (TUH)/The Adelaide and Meath Hospital, Dublin, Incorporating the National Children's Hospital (…. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Cerebral Amyloid Angiopathy, Intracranial Hemorrhages. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with atrial fibrillation (AF) on oral anticoagulation (OAC) who have a history of intracranial hemorrhage (ICrH) or cerebral amyloid angiopathy (CAA) have an elevated risk of ICrH recurrence. Left atrial appendage occlusion (LAAO) has emerged as a potential alternative to OAC for stroke prevention in high-bleeding-risk AF patients. Small observational studies suggest that LAAO may be safe and feasible in patients with ICrH, when using single or dual antiplatelet therapy or short-term OAC post-procedure, though data remain limited. This systematic review and meta-analysis aims to consolidate evidence on the safety and efficacy of LAAO in patients with prior ICrH or CAA.

Methods

We conducted a systematic review and meta-analysis examining the safety and efficacy of LAAO in patients with non-valvular AF and prior ICrH and/or CAA. PubMed/MEDLINE and EMBASE (via Scopus) databases were systematically searched from inception until 29 February 2024. Eligible studies included randomized control trials, observational studies, and case series (⩾10 participants) reporting stroke events in patients with AF and previous history of ICrH and/or CAA undergoing LAAO. Pooled incidence rates (IRs) with corresponding 95% confidence intervals (CIs) were calculated for primary outcomes (post-procedural ischemic stroke and recurrent ICrH) and secondary outcomes.

Results

Fourteen studies including 1235 patients met inclusion criteria. The pooled average follow-up period was 17.1 months. The pooled IRs for ischemic stroke, recurrent ICrH, and major hemorrhage were 2% (95% CI: 1–3%, I 2 = 2%), 2% (95% CI: 0.4–3%, I 2 = 45%) and 3% (95% CI: 1–5%, I 2 = 54%), respectively. In prespecified subgroup analyses of studies focusing on patients with intraparenchymal hemorrhage and/or CAA, pooled IRs for ischemic stroke, recurrent ICrH, and major hemorrhage IR of 4% (95% CI: 1–8%), 4% (95% CI: 0.4–10%) and 6% (95% CI: 3–12%), respectively.

Conclusions

LAAO may be a safe and effective treatment for selected AF patients with a history of ICrH and/or CAA, but the quality of evidence is poor. Future randomized controlled trials are essential to validate LAAO’s efficacy and long-term safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationCerebral Amyloid AngiopathyIntracranial HemorrhagesStrokeHumansAnticoagulants

Stichwörter der Autor:innen

CAALAAOLeft-atrial appendage occlusionatrial fibrillationcerebral amyloid angiopathyintracranial hemorrhageintraparenchymal hemorrhage

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Neurology, Tallaght University Hospital (TUH)/The Adelaide and Meath Hospital, Dublin, Incorporating the National Children's Hospital (AMNCH), Dublin, Ireland.
  • Redington-Fairview General Hospital, Skowhegan, Maine, USA.
  • Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Neurology, Boston University Medical Center, Boston University School of Medicine, Boston, MA, USA.

ORCID-Profile: Theodoros Mavridis, Paraschos Archontakis-Barakakis, Andreas Charidimou

Zitieren

APA

Mavridis, T., Archontakis-Barakakis, P., Chlorogiannis, D. D., & Charidimou, A. (2025). Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: A systematic review and meta-analysis. International Journal of Stroke, 20(9), 1049-1059. https://doi.org/10.1177/17474930251360076

Vancouver

Mavridis T, Archontakis-Barakakis P, Chlorogiannis DD, Charidimou A. Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: A systematic review and meta-analysis. International Journal of Stroke. 2025;20(9):1049-1059. doi:10.1177/17474930251360076

BibTeX
@article{Mavridis2025,
  author = {Mavridis, Theodoros and Archontakis-Barakakis, Paraschos and Chlorogiannis, David-Dimitris and Charidimou, Andreas},
  title = {Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: A systematic review and meta-analysis},
  journal = {International Journal of Stroke},
  year = {2025},
  volume = {20},
  number = {9},
  pages = {1049--1059},
  doi = {10.1177/17474930251360076}
}
Kostenlos starten →